부산지역 의원급 외래 노인 골관절염 환자의 비스테로이드소염제 사용양상평가

참고문헌 (21)

1. Altman R, "Developmentof criteria for the classification andreporting of osteoarthritis classificationof osteoarthritis of the knee", pp.1039~1049
2. Lee CK, "Osteoarthritis", 59(2), pp.246~249 (2000)
3. Brandt KD, "Management of osteoarthritis, In : Kelly WN, Ruddy S, Harris ED, Sledge CB", pp.1394~ (1997), W.B. Saunders
4. Silverstein FE, "Gastrointestional toxicity with celecoxib vs nonsteriodal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A ramdomized controlled trial", 284(10), pp.1247~1255 (2000), Celecoxib Long-term Arthritis Safety Study
5. Goldstein JL, "Reduced risk of upper gastrointestional ulcer complications with celecoxib, a novel COX-2 inhibitor", 95(7), pp.1681~1690 (2000)
6. Traversa G, "156 thritis: . Osteoarthritis of the hip", 38(11), pp.1535~1540 (1995)
7. Goodman, "Goodman & Gilman'sthe pharmacological basis of therapeutics", pp.621~
8. Ausiello JC, "Trend in medicationuse for osteoarthritis treatment", 29(5), pp.999~1005 (2002)
9. Bradley JD, "Comparison ofan antii-inflammatory dose of ibuprofen an analgesic dose of ibuprofen andacetaminophen in the treatment of patientswith osteoarthritis of the knee", pp.87~91
10. Brandt KD, "Should osteoarthritis betreated with nonsteroidal anti-inflammatorydrugs", pp.697~712 (1993)
11. Brandt KD, "Should the initialdrug be used to treat osteoarthritis pain bea nonsteroidal anti-inflammatory drug?", 28(3), pp.467~473 (2001)
12. Hochberg MC, "Guidelinesfor the medical management of osteoar", 19(5), pp.240~251 (1998)
13. Hochberg MC, "Guidelinesfor the medical management of osteoarthritis Osteoarthritis of the knee", 38(11), pp.1541~1546 (1995)
14. Cho HJ, "Comparison of prescription behaviorsbetween practicing physicians and pharmacistsby simulated patients of arthritis", 22(4), pp.511~516 (2001)
15. Lipscomb GR, "Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.", 46(2), pp.133~137 (1998)
16. Fries JF, "Therelative toxicity of nonsteroidal antiinflammatorydrugs", pp.1353~1360
17. Caffari B, "Gastroduodenal toxicity of different nonsteroidalantiinflammatory drugs", 6(1), pp.49~54 (1995)
18. Needleman P, "Selective inhibition of cyclooxygenase 2", Feb (1998), 26~35
19. Mukherjee D, "Risk of cardiovascular events associated with selective COX-2 inhibitors", 286(8), pp.954~959 (2001)
20. IMS Health, "National disease and therapeutics index, Disease report, Forth quarter 2000", pp.1538~ (2001), IMS HEALTH
21. Manek NJ, "Medical Management of Osteoarthritis", 76(5), pp.533~539 (2001)

관련 논문AI추천